National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant tissue plasminogen activator
A recombinant therapeutic agent which is chemically identical to or similar to endogenous tissue plasminogen activator (tPA). tPA is a serine protease which converts plasminogen to plasmin, a fibrinolytic enzyme. Upon administration, recombinant tPA increases plasmin enzymatic activity, resulting in hyperfibrinolysis and potential dissolution of a thrombus or embolism. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:t-PA
US brand name:Activase
Abbreviation:rt-PA



Previous:recombinant parathyroid hormone, recombinant platelet factor 4, recombinant soluble human CD4 protein, recombinant thyroid-stimulating hormone, recombinant thyrotropin alfa
Next:recombinant TNF-related apoptosis-inducing ligand, recombinant transforming growth factor-beta-2, recombinant tumor necrosis factor family protein, recombinant tyrosinase-related protein-2, recombinant vaccinia prostate-specific antigen vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov